Medications for Arthritis Pain Relief

 

Psoriatic arthritis is a kind of arthritis that affects certain persons who have the skin disorder psoriasis.

Psoriatic arthritis is an inflammatory form of arthritis.

Joint pain, stiffness, and edema are common symptoms that flare and subside. Morning stiffness affects many persons with the illness. Even modest skin psoriasis might cause considerable arthritis.

Medication to minimise inflammation, steroid injections, and joint replacement surgery are all possible treatments. 

Whereas, Upadacitinib, also known as Rinvoq, is a Janus kinase (JAK) inhibitor medicine used to treat moderately to highly active rheumatoid arthritis and psoriatic arthritis in people when methotrexate (a therapy used to treat active arthritis) did not perform effectively or could not be tolerated.

Upper respiratory tract infections (common cold, sinus infections), nausea, cough, and fever are frequent adverse effects. Upadacitinib acts by inhibiting the activity of enzymes known as Janus kinases. These enzymes are involved in the establishment of processes that contribute to inflammation, and inhibiting their action reduces inflammation in the joints.

Rinvoq can cause serious side effects such as unusual tiredness, pale skin, fast heartbeat, nausea, vomiting, loss of appetite, stomach pain, yellowing eyes or skin (jaundice), dark urine, severe stomach pain, fever, dizziness, fainting, severe nausea or vomiting, rash, itching, swelling of the face, tongue, throat, severe dizziness, and difficulty breathing.

Diarrhea, headache, nausea, upper respiratory tract infection, vomiting, runny or stuffy nose, abdominal pain, fatigue, indigestion, heartburn, decreased appetite, insomnia, back pain, frequent bowel movements, depression, bronchitis, toot abscess, sinus headache, weight loss, gastroesophageal reflux disease (GERD), migraine, cough, and rash are the most common side effects of Otezla.